Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis

Blood. 2002 Apr 1;99(7):2612-4. doi: 10.1182/blood.v99.7.2612.

Abstract

CD40 ligand (CD40L) is expressed on activated CD4(+) T lymphocytes and at the activated platelet surface. A circulating soluble form of CD40L (sCD40L) is generated by the way of a proteolytic cleavage. We measured sCD40L in the plasma of either healthy subjects; patients with inflammatory disorders and low, normal, or high platelet count (reactive thrombocytosis); or patients with essential thrombocythemia (ET). A tight correlation was found between the platelet count and plasma sCD40L. ET patients had the highest levels of sCD40L. Platelet-associated CD40L was increased in ET and reactive thrombocytosis, conditions associated with increased platelet regeneration. Platelet-associated CD40L was released upon platelet activation. In conclusion, platelets appear as a reservoir of CD40L that may be a major contributor to circulating sCD40L. Platelet-associated CD40L may be a potential marker of platelet regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Platelets / chemistry
  • Blood Platelets / physiology*
  • CD40 Ligand / analysis*
  • Cell Membrane / immunology
  • Female
  • France
  • Humans
  • Male
  • Middle Aged
  • Platelet Activation / drug effects
  • Platelet Count*
  • Regression Analysis
  • T-Lymphocytes / immunology
  • Thrombocythemia, Essential / blood*
  • Thrombocythemia, Essential / etiology
  • Thrombocytosis / blood*
  • Thrombocytosis / etiology
  • White People

Substances

  • CD40 Ligand